FDA approves Armodafinil Tablets in U.S.

As of September, U.S. sales for Nuvigil Tablets, Armodafinil Tablet’s name brand counterpart, are $515.6 million. | File photo

The U.S. Food and Drug Administration (FDA) has approved Armodafinil Tablets developed by Lupin Pharmaceuticals.

Armodafinil Tablets are the generic version of Cephalon’s Nuvigil Tablets, which Lupin has been approved to market in the U.S.

The doses for Armodafinil Tablets that have been approved by the FDA are 50 mg, 150 mg, 200 mg and 250 mg. LPI plans to begin the promotion of its newly approved drug in the U.S. in the very near future. The medication is designed to improve wakefulness in adult patients who suffer from excessive sleepiness that is linked to obstructive sleep apnea, narcolepsy or swift work disorder.

As of September, U.S. sales for Nuvigil Tablets, Armodafinil Tablet’s name brand counterpart, are $515.6 million.

Want to get notified whenever we write about Lupin Limited ?
Next time we write about Lupin Limited, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Lupin Limited Mumbai, Maharashtra 400051